These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8884975)

  • 1. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy.
    Blank LE; Barendsen GW; Prummel MF; Stalpers L; Wiersinga W; Koornneel L
    Radiother Oncol; 1996 Aug; 40(2):187-9. PubMed ID: 8884975
    [No Abstract]   [Full Text] [Related]  

  • 2. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
    Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ
    Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy.
    Schaefer U; Hesselmann S; Micke O; Schueller P; Bruns F; Palma C; Willich N
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):192-7. PubMed ID: 11777638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
    Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
    Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy.
    Akmansu M; Dirican B; Bora H; Gurel O
    Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of radiation therapy in Graves' ophthalmopathy.
    Chowdhury AD; Moriarty MJ
    Australas Radiol; 1996 Nov; 40(4):422-3. PubMed ID: 8996904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy.
    Teng CS; Crombie AL; Hall R; Ross WM
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):545-51. PubMed ID: 6784979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Graves' ophthalmopathy with irradiation].
    Slampa P; Spurný V; Seneklová Z; Krákorová D
    Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
    Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.
    Broerse JJ; Snijders-Keilholz A; Jansen JT; Zoetelief J; Klein C; Seegenschmiedt MH
    Radiother Oncol; 1999 Dec; 53(3):205-8. PubMed ID: 10660199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy.
    Kinyoun JL; Kalina RE; Brower SA; Mills RP; Johnson RH
    Arch Ophthalmol; 1984 Oct; 102(10):1473-6. PubMed ID: 6548374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitory blindness after retrobulbar irradiation of Graves' ophthalmopathy.
    Nygaard B; Specht L
    Lancet; 1998 Mar; 351(9104):725-6. PubMed ID: 9504522
    [No Abstract]   [Full Text] [Related]  

  • 13. Orbital irradiation in the treatment of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Panicucci M; Bogazzi F; Pinchera A
    Bull Soc Belge Ophtalmol; 1988; 226():71-83. PubMed ID: 3151769
    [No Abstract]   [Full Text] [Related]  

  • 14. Does 131 I therapy for Graves' disease cause cancer?
    Hoffman DA; Lundin FE
    N Engl J Med; 1978 Sep; 299(12):662. PubMed ID: 581091
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
    Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
    Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
    Koshiyama H; Koh T; Fujiwara K; Hayakawa K; Shimbo S; Misaki T
    Thyroid; 1994; 4(4):409-13. PubMed ID: 7711503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy for Graves' ophthalmopathy].
    Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
    Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of radiotherapy in Graves' ophthalmopathy].
    Jaulerry C
    J Fr Ophtalmol; 2004 Sep; 27(7):825-7. PubMed ID: 15499286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The current role of radiotherapy in immunogenic exophthalmos].
    Malinverni G; Giordana C; Rosmino C; Mancini A; Sala S
    Radiol Med; 1994 Nov; 88(5):665-9. PubMed ID: 7824786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
    Ott M; Breiter N; Albrecht CF; Pradier O; Hess CF; Schmidberger H
    Br J Radiol; 2002 Jun; 75(894):514-7. PubMed ID: 12124238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.